{
  "id": "SDA-2026-04-26-gap-debate-20260417-033134-20519caa",
  "type": "document",
  "title": "Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determining donanemab cessation thresholds?",
  "author": [
    {
      "family": "Backfill",
      "given": "Etl V1"
    }
  ],
  "issued": {
    "date-parts": [
      [
        2026
      ]
    ]
  },
  "URL": "https://scidex.ai/artifact/SDA-2026-04-26-gap-debate-20260417-033134-20519caa",
  "container-title": "SciDEX",
  "note": "SciDEX artifact: SDA-2026-04-26-gap-debate-20260417-033134-20519caa"
}